<DOC>
	<DOCNO>NCT00422890</DOCNO>
	<brief_summary>Efficacy safety 5-Azacytidin treatment haematological relapse patient suffer acute myeloid leukaemia myelodysplastic syndrome fall CD34-chimerism hematopoietic stem cell transplantation .</brief_summary>
	<brief_title>Treatment Imminent Haematological Relapse Patients With AML MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine ( VidazaÂ® )</brief_title>
	<detailed_description />
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>Screening phase : Age &gt; 18 year Patients CD34+ AML MDS postallogeneic HSCT Written patient consent consultation Treatment phase AML/MDS : donor chimerism &lt; 80 % CD34+ subpopulation follow allogeneic HSCT patient CD34+ AML MDS , haematological relapse ( blast &lt; 5 % bone marrow ) Leukocytes &gt; 3 Gpt/l platelet &gt; 75 Gpt/l ( transfusionindependent ) Known intolerance 5azacitidine mannitol Uncontrollable infectious disease Patients active hepatitis B C HIV infection Severe hepatic function impairment ( ASAT ALAT may three time normal value ) hepatic cirrhosis , malignant hepatic tumour Renal function impairment ( creatinine &gt; twice normal value , creatinine clearance &lt; 50 ml/min ) Pregnancy lactation Women childbearing age , except meet follow criterion : postmenopausal ( 12 month natural amenorrhoea ) postoperative ( 6 week bilateral ovarectomy without hysterectomy ) regular correct use contraceptive method error rate &lt; 1 % per year ( e.g . implant , depot injection , combine oral contraceptive , intrauterine device IUD , whereby hormonal coil Pearl Index &lt; 1 % safe copper coil ) sexual abstinence Partner vasectomy Men use one follow contraception : sexual abstinence post vasectomy condom Participation patient drug trial outside indication allogeneic transplantation four week study initiation Addictive illnesses prevent person concern comprehending nature impact , well potentical consequence clinical trial Evidence patient may intentionally comply protocol , e.g . lack cooperation With exception know allergic reaction intolerance 5azacitidine , criterion apply screen phase .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Acute myeloid leukaemia Myelodysplastic syndrome</keyword>
</DOC>